JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4726
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.57B
| $623K | ﹤0.01% |
15,084
+14,449
| +2,275% | +$603K |
2023 Q3
5 quarters
|
|
|
XHYC
4727
DELISTED
BondBloxx USD High Yield Bond Consumer Cyclicals Sector ETF
XHYC
| $621K | ﹤0.01% |
16,646
-95
| -0.6% | -$3.57K |
2024 Q2
2 quarters
|
|
4728
Artesian Resources
ARTNA
$347M
| $619K | ﹤0.01% |
19,576
+3,541
| +22% | +$121K |
2013 Q2
46 quarters
|
|
4729
Novavax
NVAX
$1.73B
| $616K | ﹤0.01% |
76,576
-3,299
| -4% | -$31.8K |
2014 Q3
41 quarters
|
|
4730
VanEck Long Muni ETF
MLN
$637M
| $615K | ﹤0.01% |
34,417
+1,985
| +6% | +$35.7K |
2023 Q3
5 quarters
|
|
4731
CALL
NovoCure
NVCR
$1.74B
| $614K | ﹤0.01% |
20,600
-69,600
| -77% | -$1.47M |
2024 Q3
1 quarter
|
|
|
EHAB
4732
DELISTED
Enhabit
EHAB
| $614K | ﹤0.01% |
78,574
-226,671
| -74% | -$1.72M |
2022 Q3
9 quarters
|
|
4733
Entrada Therapeutics
TRDA
$209M
| $613K | ﹤0.01% |
35,470
+24,658
| +228% | +$447K |
2022 Q4
8 quarters
|
|
|
ADAM
4734
Adamas Trust
ADAM
$702M
| $612K | ﹤0.01% |
100,934
+58,388
| +137% | +$343K |
2015 Q3
37 quarters
|
|
|
API
4735
Agora
API
$345M
| $611K | ﹤0.01% |
146,850
-463,607
| -76% | -$1.9M |
2020 Q2
18 quarters
|
|
4736
United States Natural Gas Fund
UNG
$530M
| $610K | ﹤0.01% |
36,276
-127,725
| -78% | -$1.83M |
2013 Q2
46 quarters
|
|
4737
1stdibs.com
DIBS
$135M
| $610K | ﹤0.01% |
172,213
+65,806
| +62% | +$266K |
2021 Q2
14 quarters
|
|
4738
PUT
Moderna
MRNA
$75.9B
| $607K | ﹤0.01% |
14,600
-7,600
| -34% | -$363K |
2020 Q1
19 quarters
|
|
4739
Malibu Boats
MBUU
$453M
| $607K | ﹤0.01% |
16,142
-5,743
| -26% | -$238K |
2014 Q1
43 quarters
|
|
4740
PUT
JD.com
JD
$34.8B
| $607K | ﹤0.01% |
17,500
| – | – |
2023 Q4
4 quarters
|
|
4741
State Street SPDR S&P International Dividend ETF
DWX
$509M
| $607K | ﹤0.01% |
17,353
-9,013
| -34% | -$329K |
2017 Q1
31 quarters
|
|
4742
RGC Resources
RGCO
$227M
| $604K | ﹤0.01% |
30,129
+15,434
| +105% | +$320K |
2023 Q1
7 quarters
|
|
4743
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$613M
| $602K | ﹤0.01% |
7,879
-1,802
| -19% | -$144K |
2022 Q4
8 quarters
|
|
4744
Stratasys
SSYS
$762M
| $601K | ﹤0.01% |
67,587
-9,575
| -12% | -$82.5K |
2022 Q2
10 quarters
|
|
4745
Virginia National Bankshares
VABK
$255M
| $600K | ﹤0.01% |
15,715
+8,655
| +123% | +$354K |
2023 Q1
7 quarters
|
|
|
SEVN
4746
Seven Hills Realty Trust
SEVN
$153M
| $599K | ﹤0.01% |
45,793
+21,923
| +92% | +$292K |
2023 Q4
4 quarters
|
|
4747
Grupo Aeroportuario Centro Norte
OMAB
$4.55B
| $598K | ﹤0.01% |
8,719
-4,571
| -34% | -$311K |
2016 Q3
33 quarters
|
|
|
VRNA
4748
DELISTED
Verona Pharma
VRNA
| $597K | ﹤0.01% |
12,863
-1,197
| -9% | -$44.9K |
2022 Q3
9 quarters
|
|
4749
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.01B
| $597K | ﹤0.01% |
7,730
-10,974
| -59% | -$870K |
2021 Q2
14 quarters
|
|
|
PHLT
4750
DELISTED
Performant Healthcare Inc
PHLT
| $596K | ﹤0.01% |
197,508
+115,000
| +139% | +$395K |
2023 Q2
6 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.